{
    "nctId": "NCT03940625",
    "briefTitle": "Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping",
    "officialTitle": "Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Myocardial Damage, Cardiotoxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 69,
    "primaryOutcomeMeasure": "reduction of the left ventricular ejection fraction (LV-EF) by 10% to under 50%",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Planned therapy with an anthracycline and at least 1 year follow up\n* \\>18 years of age\n* written informed consent\n\nExclusion Criteria:\n\n* prior cardiovascular disease\n* diabetes mellitus\n* previous therapy with anthracyclines",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}